- Home
- STRM vs INAB Comparison
STRM vs INAB Comparison
Compare STRM & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRM
- INAB
- Stock Information
- Founded
- STRM 1989
- INAB 2016
- Country
- STRM United States
- INAB United States
- Employees
- STRM N/A
- INAB N/A
- Industry
- STRM EDP Services
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- STRM Technology
- INAB Health Care
- Exchange
- STRM Nasdaq
- INAB Nasdaq
- Market Cap
- STRM 15.4M
- INAB 14.5M
- IPO Year
- STRM 1996
- INAB 2021
- Fundamental
- Price
- STRM $5.18
- INAB $0.13
- Analyst Decision
- STRM
- INAB Strong Buy
- Analyst Count
- STRM 0
- INAB 2
- Target Price
- STRM N/A
- INAB $3.60
- AVG Volume (30 Days)
- STRM 180.1K
- INAB 6.9M
- Earning Date
- STRM 06-10-2025
- INAB 05-07-2025
- Dividend Yield
- STRM N/A
- INAB N/A
- EPS Growth
- STRM N/A
- INAB N/A
- EPS
- STRM N/A
- INAB N/A
- Revenue
- STRM $17,901,000.00
- INAB N/A
- Revenue This Year
- STRM $18.64
- INAB N/A
- Revenue Next Year
- STRM N/A
- INAB N/A
- P/E Ratio
- STRM N/A
- INAB N/A
- Revenue Growth
- STRM N/A
- INAB N/A
- 52 Week Low
- STRM $1.82
- INAB $0.11
- 52 Week High
- STRM $9.75
- INAB $1.74
- Technical
- Relative Strength Index (RSI)
- STRM 84.54
- INAB 39.26
- Support Level
- STRM $2.07
- INAB $0.13
- Resistance Level
- STRM $5.20
- INAB $0.19
- Average True Range (ATR)
- STRM 0.14
- INAB 0.02
- MACD
- STRM 0.34
- INAB 0.00
- Stochastic Oscillator
- STRM 99.21
- INAB 28.93
About STRM Streamline Health Solutions Inc.
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.